Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
23:24
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

 

BSH 2020 VIRTUAL

 

9-14 November 2020 Virtual Conference
FAQs
   
Discussion forum - BSH 2020 VIRTUAL
    Topic - Red Cell Disorders

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER.
 

Poster: 159
Visits: 28
Title: Improving the Laboratory Diagnosis of Pyruvate Kinase Deficiency
Authors: Claire Laas , Claire Laas:Red Cell Centre,Viapath,London,United Kingdom|Chris Lambert:Red Cell Centre,Viapath,London,United Kingdom|Tania Senior McKenzie:Red Cell Centre,Viapath,London,United Kingdom|David Rees:Department of Haematological Medicine,Kings CollegeHospital,London,United Kingdom|Barnaby Clark:Precision Medicine,Kings College Hospital,London,United Kingdom
Centre: 

You must be registered to reply or comment.

IMPROVING THE LABORATORY DIAGNOSIS OF PYRUVATE KINASE DEFICIENCY

Claire Laas
Thread initiator
Subspeciality
Reg: 10/26/2020 8:59:00 AM

Comment# 1

I invite healthcare professionals to open debate around the issues raised in my poster, both those relating to research and to clinical practice.

Comment added on 11/9/2020 12:01:00 PM 
     
You must be registered to reply or comment.



Most viewed poster for this congress
Poster: 1
Visits: 544
Title: Whole genome profiling of adult B-other acute lymphoblastic leukaemia on the UKALL14 trial
Authors: Daniel Leongamornlert , E. Barretta, S. Lee, T. Creasey, R. Mitchell, A. A. Kirkwood, L Clifton-Hadley, P. Patrick, P. Campbell, B. Patel, A. Moorman, A. K. Fielding, E. Papaemmanuil
Centre: 

Poster most viewed in this topic
Poster: 147
Visits: 106
Title: Assessment of longer-term efficacy, safety, and haematological improvement in the phase 3, randomised, double-blind, placebo-controlled MEDALIST trial of luspatercept to treat anaemia in patients with lower-risk myelodysplastic syndromes with ring sideroblasts who require red blood cell transfusions
Authors: Ghulam J. Mufti , o Ghulam J. Mufti, Paresh Vyas, Rena Buckstein, Valeria Santini, María Díez-Campelo, Carlo Finelli, Osman Ilhan, Mikkael A. Sekeres, Rami S. Komrokji, Amer M. Zeidan, Amit K. Verma, Abderrahmane Laadem, Peter G. Linde, Alan F. List, Uwe Platzbecker, Guillermo Garcia-Manero, Pierre Fenaux
Centre: 


 




PosterSessionOnline
Logo Draft
 
Logo Cert